WHO GMP gap identified during internal gap assessment – WHO inspector expectations explained



Published on 28/01/2026

Addressing WHO GMP Gaps Identified in Internal Assessments: A Comprehensive Playbook

Maintaining compliance with WHO GMP standards is critical for the pharmaceutical industry. Identifying gaps during internal assessments not only prepares organizations for official inspections but also enhances overall quality management systems (QMS). This article outlines a playbook that equips professionals in manufacturing, quality control, regulatory affairs, and engineering with actionable steps to effectively address those gaps.

Following this guide, you will learn to diagnose potential issues, implement containment actions, and develop a robust corrective and preventive action (CAPA) strategy to ensure compliance. This comprehensive framework also ensures your documentation is inspection-ready and aligns with expectations set forth by regulatory bodies.

Symptoms/Signals on the Floor or in the Lab

Recognizing early signals of potential WHO GMP compliance gaps can prevent minor issues from escalating. Key symptoms may include:

  • Inconsistent Product Quality: Variability in batch characteristics that does not meet specifications.
  • Lack of Proper Documentation: Incomplete batch records or missing logs may signal issues in your documentation practices.
  • Frequent Deviations: Repeated deviations from
standard operating procedures (SOPs) may indicate systemic problems.
  • Internal Audit Findings: Non-conformances discovered during internal audits should serve as immediate red flags.
  • Audit Observations: Feedback from previous audits, particularly regarding deficiencies in QMS or SOP adherence.
  • Likely Causes

    When investigating WHO GMP gaps, it is essential to categorize potential causes for a structured approach:

    Materials

    Supplier reliability, raw material quality, and batch-to-batch variability can significantly impact compliance. Ensure rigorous qualification and testing of all materials used in manufacturing.

    Method

    Inadequate SOPs or outdated methodologies may lead to inconsistent practices. Ensure all methods are current and validated according to established protocols.

    Machine

    Equipment malfunction or inadequate maintenance can cause significant production issues. Regular maintenance schedules and calibration checks are crucial.

    Man

    Human error remains a significant contributor to non-compliance. Extensive training programs, along with ensuring adequate staffing levels, are essential.

    Measurement

    Poor measurement and monitoring techniques lead to inaccurate data, which can directly affect product quality. Implement robust data integrity measures.

    Environment

    Contamination risks can arise from improper environmental controls. Validation of cleaning procedures and environmental monitoring must be robust.

    Symptom Likely Cause Initial Test/Action
    Inconsistent product quality Material variability Perform raw material assessments
    Lack of proper documentation Inadequate training Review training logs
    Frequent deviations Outdated procedures Reassess SOPs

    Immediate Containment Actions (First 60 Minutes)

    Upon identifying a WHO GMP gap, prompt containment is vital:

    • Cease Production: If safety or quality is jeopardized, halt production immediately.
    • Notify Key Personnel: Inform quality assurance (QA), quality control (QC), and production managers right away.
    • Isolate Affected Batches: Secure any affected batch materials in a controlled area to prevent further use.
    • Initial Documentation: Record observations and immediate actions taken, signing off for accountability.
    • Implement Temporary Controls: Depending on the gap, temporary controls might include additional monitoring or manual checks.

    Investigation Workflow (Data to Collect + How to Interpret)

    Following containment, an organized investigation is critical. The following steps outline what data to collect and how to interpret it effectively:

    1. Data Collection: Gather all relevant records, including batch production logs, equipment maintenance histories, and any deviations reports.
    2. Data Analysis: Analyze data trends indicating non-compliance and correlate findings with existing STP (SOPs) and processes.
    3. Interviews: Conduct interviews with key personnel involved in affected operations to obtain contextual insights.
    4. Document Findings: Create a ‘fact file’ to record all findings. This file serves as critical evidence during audits.

    Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

    Determining the root causes requires selecting appropriate investigative tools:

    5-Why Analysis

    Use this technique for straightforward problems where direct relationships exist. It facilitates simple problem-solving by asking “why” repeatedly until the root cause is uncovered.

    Fishbone Diagram

    This tool is beneficial for complex issues with multiple contributing factors. It visually breaks down potential causes by categories, making it easier to identify various areas of impact.

    Fault Tree Analysis

    Utilize this method when assessing systemic issues in processes or machinery. It allows for a structured approach to exploring logical possibilities leading to a failure.

    Related Reads

    CAPA Strategy (Correction, Corrective Action, Preventive Action)

    A robust CAPA strategy is essential for addressing identified gaps effectively:

    • Correction: Immediately rectify the issue within the affected batch or process. This might include reworking or discarding non-compliant products.
    • Corrective Action: Implement systemic changes to rectify the underlying issue, such as revising SOPs, retraining personnel, or improving equipment maintenance.
    • Preventive Action: Proactive measures to enhance compliance long-term. This includes routine training refreshers, scheduled audits, and predictive maintenance strategies.

    Control Strategy & Monitoring (SPC/Trending, Sampling, Alarms, Verification)

    To prevent future issues, a solid control strategy is necessary:

    • Statistical Process Control (SPC): Monitor critical parameters in real-time to detect variability before it becomes a compliance issue.
    • Trending Analysis: Enable regular review of data trends for early indication of deviations from established performance norms.
    • Sampling Plans: Establish robust sampling plans for incoming materials and in-process products, ensuring they comply with WHO PQ standards.
    • Alarm Systems: Install alarms for critical exceedances to facilitate immediate operator intervention.
    • Verification Processes: Incorporate robust verification practices to assure that control measures are working effectively.

    Validation / Re-qualification / Change Control Impact (When Needed)

    Changes resulting from CAPA actions often require re-validation or re-qualification:

    • Validation: Ensure new processes or methodologies undergo rigorous validation as per the established protocols.
    • Re-qualification: For changed equipment or processes, re-qualification tests should confirm compliance with specifications.
    • Change Control: Adopt a formal change control process when initiating any modifications that could impact product quality.

    Inspection Readiness: What Evidence to Show (Records, Logs, Batch Docs, Deviations)

    To prepare for inspections, maintain a repository of all relevant documentation:

    • Batch Production Records: Ensure all records are complete, accurate, and readily available for review.
    • Logs of Deviations: Document all deviations, their investigations, and corrective actions taken.
    • SOPs: Ensure that all SOPs are current, available, and adhered to within the organization.
    • Audit Trails: Maintain comprehensive audit trails demonstrating adherence to protocols and the effectiveness of controls.

    FAQs

    What are common signs of WHO GMP compliance gaps?

    Common signs include inconsistent product quality, incomplete documentation, frequent deviations, and negative internal audit findings.

    How do I prioritize found deficiencies?

    Assess and categorize deficiencies based on potential impact on patient safety, product quality, and compliance requirements.

    What is a CAPA strategy?

    A CAPA strategy details the steps for correction, corrective actions to address root causes, and preventive actions to mitigate recurrence.

    Why is training important in addressing GMP gaps?

    Training ensures that all personnel are knowledgeable about current procedures and standards, reducing instances of human error.

    How often should internal audits occur to maintain GMP compliance?

    Internal audits should be performed regularly, generally at least annually, or more frequently based on identified risks.

    What documentation is essential for FDA inspections?

    Maintain complete batch records, deviation logs, SOPs, training records, and audit trails to demonstrate compliance.

    When is a re-validation necessary?

    Re-validation is necessary following significant process changes, equipment updates, or following major CAPA implementations.

    What role do monitoring systems play in GMP compliance?

    Monitoring systems are crucial for real-time observation of process parameters, ensuring immediate action can be taken when deviations occur.

    What’s the difference between corrective action and preventive action?

    Corrective actions address existing issues, while preventive actions aim to mitigate the risk of future occurrences.

    What best practices can help ensure readiness for inspections?

    Regular training, robust documentation practices, proactive CAPA implementation, and systematic audits can enhance inspection readiness.

    How can SPC contribute to quality assurance?

    SPC tools help visualize process variability, allowing for timely interventions before quality issues emerge.

    Where can I find guidance on WHO GMP standards?

    Refer to the WHO guidance documents on GMP compliance for detailed regulatory standards and expectations.

    Pharma Tip:  WHO GMP Gaps? Stepwise Compliance Solutions for Global Supply